reference/16138382

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16138382

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	146
issn	1475-6374 1475-6366
issueIdentifier	1
pageRange	137-146
publicationName	Journal of Enzyme Inhibition and Medicinal Chemistry
startingPage	137
bibliographicCitation	Granchi C, Rizzolio F, Bordoni V, Caligiuri I, Manera C, Macchia M, Minutolo F, Martinelli A, Giordano A, Tuccinardi T. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2015 Feb 11;31(1):137–46. doi: 10.3109/14756366.2015.1010530.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06638ac4b2dafbf3816cda622baed0d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddb92bbd2103e2a9d323d8e5df28d3dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8924dedb0110242b07e1b92e10327b71 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_109b638e713b49d7038c1bf639b5a121 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50350f21813791248f613f5e68c4ab1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cbb90d87ec5fc82c166483905665960 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b443d9f051be68d1e59778f61d0b0134 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_915278c69439ba82e7743fcafce420bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e00d46f35c1e46dafcc6b85c099a993e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7379-5743 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e3e887c9a2bcba277f76a6b9ec811ea
date	2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3109/14756366.2015.1010530 https://pubmed.ncbi.nlm.nih.gov/25669350
isPartOf	https://portal.issn.org/resource/ISSN/1475-6374 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29851 https://portal.issn.org/resource/ISSN/1475-6366
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0000901 http://id.nlm.nih.gov/mesh/M0014025 http://id.nlm.nih.gov/mesh/M0267279 http://id.nlm.nih.gov/mesh/M0015642
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010081Q000494 http://id.nlm.nih.gov/mesh/D004791Q000494 http://id.nlm.nih.gov/mesh/D008994Q000037 http://id.nlm.nih.gov/mesh/D000970Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D062105 http://id.nlm.nih.gov/mesh/D000970Q000737 http://id.nlm.nih.gov/mesh/D015394 http://id.nlm.nih.gov/mesh/D000581Q000037 http://id.nlm.nih.gov/mesh/D004791Q000737 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D010081Q000737 http://id.nlm.nih.gov/mesh/D000581Q000378 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D010081Q000138 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000970Q000138 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D008994Q000378 http://id.nlm.nih.gov/mesh/D004791Q000138
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3c27d67d9faae66c263d6338f1b4fdbb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0b869ad16ce197d4bea1a7444d3d9cd0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ab0cd01e3c1b2ad9b37709ef9553307

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485206115 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2166 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11343

Total number of triples: 65.